NFE2L2 and cancer: Due to the critical role that the immune system plays in the anti-cancer response [20], coupled with the fact that oxidative stress within the tumour microenvironment broadly inhibits immune cell effector functions [24, 25], we hypothesized that drug-induced NRF2 activation may positively contribute to anti-cancer immune surveillance by alleviating oxidative stress.